rs201914751
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM2BP4_StrongBP6_Very_StrongBS1
The NM_001038603.3(MARVELD2):c.592G>A(p.Val198Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000966 in 1,614,192 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001038603.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MARVELD2 | NM_001038603.3 | c.592G>A | p.Val198Met | missense_variant | 2/7 | ENST00000325631.10 | NP_001033692.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MARVELD2 | ENST00000325631.10 | c.592G>A | p.Val198Met | missense_variant | 2/7 | 1 | NM_001038603.3 | ENSP00000323264 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000282 AC: 71AN: 251484Hom.: 0 AF XY: 0.000235 AC XY: 32AN XY: 135916
GnomAD4 exome AF: 0.0000944 AC: 138AN: 1461894Hom.: 0 Cov.: 35 AF XY: 0.0000935 AC XY: 68AN XY: 727248
GnomAD4 genome AF: 0.000118 AC: 18AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74478
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 19, 2021 | This variant is associated with the following publications: (PMID: 30406641) - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 15, 2022 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 22, 2017 | p.Val198Met in exon 2 of MARVELD2: This variant is not expected to have clinical significance because it has been identified in 0.4% (72/18870) of East Asian ch romosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitu te.org; dbSNP rs201914751). ACMG/AMP Criteria applied: BS1. - |
MARVELD2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 23, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at